- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 235/32 - Acides benzimidazolcarbamiques-2, substitués ou nonLeurs estersLeurs thio-analogues
Détention brevets de la classe C07D 235/32
Brevets de cette classe: 51
Historique des publications depuis 10 ans
|
4
|
2
|
6
|
4
|
3
|
2
|
5
|
3
|
3
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Korea University Research and Business Foundation | 3209 |
5 |
| Beth Israel Deaconess Medical Center, Inc. | 862 |
4 |
| Children's Medical Center Corporation | 1944 |
4 |
| The Johns Hopkins University | 5849 |
3 |
| Intervet International B.V. | 1345 |
2 |
| Korea Research Institute of Chemical Technology | 1458 |
2 |
| University of Washington through its Center for Commercialization | 504 |
2 |
| Institute of Organic Chemistry and Biochemistry AS CR V.v.i. | 32 |
2 |
| Boehringer Ingelheim International GmbH | 4491 |
1 |
| Merck Patent GmbH | 5691 |
1 |
| Bayer Intellectual Property GmbH | 2396 |
1 |
| Amgen Inc. | 4385 |
1 |
| Board of Regents of the University of Nebraska | 795 |
1 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 822 |
1 |
| Carna Biosciences, Inc. | 65 |
1 |
| Gilead Sciences, Inc. | 2210 |
1 |
| Intervet Inc. | 918 |
1 |
| Istituto Superiore di Sanita | 74 |
1 |
| Kyoto University | 2900 |
1 |
| MediciNova, Inc. | 91 |
1 |
| Autres propriétaires | 15 |